Researcher profile

Matthew Stephens

Matthew Stephens contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
14works
0followers
10topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

14 published item(s)

preprint2026arXiv

A New Family of Poisson Non-negative Matrix Factorization Methods Using the Shifted Log Link

Poisson non-negative matrix factorization (NMF) is a widely used method to find interpretable "parts-based" decompositions of count data. While many variants of Poisson NMF exist, existing methods assume that the "parts" in the decomposition combine additively. This assumption may be natural in some settings, but not in others. Here we introduce Poisson NMF with the shifted-log link function to relax this assumption. The shifted-log link function has a single tuning parameter, and as this parameter varies the model changes from assuming that parts combine additively (i.e., standard Poisson NMF) to assuming that parts combine more multiplicatively. We provide an algorithm to fit this model by maximum likelihood, and also an approximation that substantially reduces computation time for large, sparse datasets (computations scale with the number of non-zero entries in the data matrix). We illustrate these new methods on a variety of real datasets. Our examples show how the choice of link function in Poisson NMF can substantively impact the results, and how in some settings the use of a shifted-log link function may improve interpretability compared with the standard, additive link.

preprint2020arXiv

Flexible signal denoising via flexible empirical Bayes shrinkage

Signal denoising---also known as non-parametric regression---is often performed through shrinkage estimation in a transformed (e.g., wavelet) domain; shrinkage in the transformed domain corresponds to smoothing in the original domain. A key question in such applications is how much to shrink, or, equivalently, how much to smooth. Empirical Bayes shrinkage methods provide an attractive solution to this problem; they use the data to estimate a distribution of underlying "effects", hence automatically select an appropriate amount of shrinkage. However, most existing implementations of Empirical Bayes shrinkage are less flexible than they could be--both in their assumptions on the underlying distribution of effects, and in their ability to handle heterskedasticity---which limits their signal denoising applications. Here we address this by taking a particularly flexible, stable and computationally convenient Empirical Bayes shrinkage method, and we apply it to several signal denoising problems. These applications include smoothing of Poisson data and heteroskedastic Gaussian data. We show through empirical comparisons that the results are competitive with other methods, including both simple thresholding rules and purpose-built Empirical Bayes procedures. Our methods are implemented in the R package smashr, "SMoothing by Adaptive SHrinkage in R," available at https://www.github.com/stephenslab/smashr

preprint2014arXiv

An estimate of the average number of recessive lethal mutations carried by humans

The effects of inbreeding on human health depend critically on the number and severity of recessive, deleterious mutations carried by individuals. In humans, existing estimates of these quantities are based on comparisons between consanguineous and non-consanguineous couples, an approach that confounds socioeconomic and genetic effects of inbreeding. To circumvent this limitation, we focused on a founder population with almost complete Mendelian disease ascertainment and a known pedigree. By considering all recessive lethal diseases reported in the pedigree and simulating allele transmissions, we estimated that each haploid set of human autosomes carries on average 0.29 (95% credible interval [0.10, 0.83]) autosomal, recessive alleles that lead to complete sterility or severe disorders at birth or before reproductive age when homozygous. Comparison to existing estimates of the deleterious effects of all recessive alleles suggests that a substantial fraction of the burden of autosomal, recessive variants is due to single mutations that lead to death between birth and reproductive age. In turn, the comparison to estimates from other eukaryotes points to a surprising constancy of the average number of recessive lethal mutations across organisms with markedly different genome sizes.

preprint2014arXiv

Bayesian methods for genetic association analysis with heterogeneous subgroups: From meta-analyses to gene-environment interactions

Genetic association analyses often involve data from multiple potentially-heterogeneous subgroups. The expected amount of heterogeneity can vary from modest (e.g., a typical meta-analysis) to large (e.g., a strong gene--environment interaction). However, existing statistical tools are limited in their ability to address such heterogeneity. Indeed, most genetic association meta-analyses use a "fixed effects" analysis, which assumes no heterogeneity. Here we develop and apply Bayesian association methods to address this problem. These methods are easy to apply (in the simplest case, requiring only a point estimate for the genetic effect and its standard error, from each subgroup) and effectively include standard frequentist meta-analysis methods, including the usual "fixed effects" analysis, as special cases. We apply these tools to two large genetic association studies: one a meta-analysis of genome-wide association studies from the Global Lipids consortium, and the second a cross-population analysis for expression quantitative trait loci (eQTLs). In the Global Lipids data we find, perhaps surprisingly, that effects are generally quite homogeneous across studies. In the eQTL study we find that eQTLs are generally shared among different continental groups, and discuss consequences of this for study design.

preprint2013arXiv

A likelihood-based scoring method for peptide identification using mass spectrometry

Mass spectrometry provides a high-throughput approach to identify proteins in biological samples. A key step in the analysis of mass spectrometry data is to identify the peptide sequence that, most probably, gave rise to each observed spectrum. This is often tackled using a database search: each observed spectrum is compared against a large number of theoretical "expected" spectra predicted from candidate peptide sequences in a database, and the best match is identified using some heuristic scoring criterion. Here we provide a more principled, likelihood-based, scoring criterion for this problem. Specifically, we introduce a probabilistic model that allows one to assess, for each theoretical spectrum, the probability that it would produce the observed spectrum. This probabilistic model takes account of peak locations and intensities, in both observed and theoretical spectra, which enables incorporation of detailed knowledge of chemical plausibility in peptide identification. Besides placing peptide scoring on a sounder theoretical footing, the likelihood-based score also has important practical benefits: it provides natural measures for assessing the uncertainty of each identification, and in comparisons on benchmark data it produced more accurate peptide identifications than other methods, including SEQUEST. Although we focus here on peptide identification, our scoring rule could easily be integrated into any downstream analyses that require peptide-spectrum match scores.

preprint2013arXiv

Efficient Algorithms for Multivariate Linear Mixed Models in Genome-wide Association Studies

Multivariate linear mixed models (mvLMMs) have been widely used in many areas of genetics, and have attracted considerable recent interest in genome-wide association studies (GWASs). However, fitting mvLMMs is computationally non-trivial, and no existing method is computationally practical for performing the likelihood ratio test (LRT) for mvLMMs in GWAS settings with moderate sample size n. The existing software MTMM perform an approximate LRT for two phenotypes, and as we find, its p values can substantially understate the significance of associations. Here, we present novel computationally-efficient algorithms for fitting mvLMMs, and computing the LRT in GWAS settings. After a single initial eigen-decomposition (with complexity O(n^3)) the algorithms i) reduce computational complexity (per iteration of the optimizer) from cubic to linear in n; and ii) in GWAS analyses, reduces per-marker complexity from cubic to quadratic in n. These innovations make it practical to compute the LRT for mvLMMs in GWASs for tens of thousands of samples and a moderate number of phenotypes (~2-10). With simulations, we show that the LRT provides correct control for type I error. With both simulations and real data we find that the LRT is more powerful than the approximate LRT from MTMM, and illustrate the benefits of analyzing more than two phenotypes. The method is implemented in the GEMMA software package, freely available at http://stephenslab.uchicago.edu/software.html

preprint2013arXiv

Wavelet-based genetic association analysis of functional phenotypes arising from high-throughput sequencing assays

Understanding how genetic variants influence cellular-level processes is an important step towards understanding how they influence important organismal-level traits, or "phenotypes", including human disease susceptibility. To this end scientists are undertaking large-scale genetic association studies that aim to identify genetic variants associated with molecular and cellular phenotypes, such as gene expression, transcription factor binding, or chromatin accessibility. These studies use high-throughput sequencing assays (e.g. RNA-seq, ChIP-seq, DNase-seq) to obtain high-resolution data on how the traits vary along the genome in each sample. However, typical association analyses fail to exploit these high-resolution measurements, instead aggregating the data at coarser resolutions, such as genes, or windows of fixed length. Here we develop and apply statistical methods that better exploit the high-resolution data. The key idea is to treat the sequence data as measuring an underlying "function" that varies along the genome, and then, building on wavelet-based methods for functional data analysis, test for association between genetic variants and the underlying function. Applying these methods to identify genetic variants associated with chromatin accessibility (dsQTLs) we find that they identify substantially more associations than a simpler window-based analysis, and in total we identify 772 novel dsQTLs not identified by the original analysis.

preprint2012arXiv

A statistical framework for joint eQTL analysis in multiple tissues

Mapping expression Quantitative Trait Loci (eQTLs) represents a powerful and widely-adopted approach to identifying putative regulatory variants and linking them to specific genes. Up to now eQTL studies have been conducted in a relatively narrow range of tissues or cell types. However, understanding the biology of organismal phenotypes will involve understanding regulation in multiple tissues, and ongoing studies are collecting eQTL data in dozens of cell types. Here we present a statistical framework for powerfully detecting eQTLs in multiple tissues or cell types (or, more generally, multiple subgroups). The framework explicitly models the potential for each eQTL to be active in some tissues and inactive in others. By modeling the sharing of active eQTLs among tissues this framework increases power to detect eQTLs that are present in more than one tissue compared with "tissue-by-tissue" analyses that examine each tissue separately. Conversely, by modeling the inactivity of eQTLs in some tissues, the framework allows the proportion of eQTLs shared across different tissues to be formally estimated as parameters of a model, addressing the difficulties of accounting for incomplete power when comparing overlaps of eQTLs identified by tissue-by-tissue analyses. Applying our framework to re-analyze data from transformed B cells, T cells and fibroblasts we find that it substantially increases power compared with tissue-by-tissue analysis, identifying 63% more genes with eQTLs (at FDR=0.05). Further the results suggest that, in contrast to previous analyses of the same data, the majority of eQTLs detectable in these data are shared among all three tissues.

preprint2012arXiv

Integrated analysis of variants and pathways in genome-wide association studies using polygenic models of disease

Many common diseases are highly polygenic, modulated by a large number genetic factors with small effects on susceptibility to disease. These small effects are difficult to map reliably in genetic association studies. To address this problem, researchers have developed methods that aggregate information over sets of related genes, such as biological pathways, to identify gene sets that are enriched for genetic variants associated with disease. However, these methods fail to answer a key question: which genes and genetic variants are associated with disease risk? We develop a method based on sparse multiple regression that simultaneously identifies enriched pathways, and prioritizes the variants within these pathways, to locate additional variants associated with disease susceptibility. A central feature of our approach is an estimate of the strength of enrichment, which yields a coherent way to prioritize variants in enriched pathways. We illustrate the benefits of our approach in a genome-wide association study of Crohn's disease with ~440,000 genetic variants genotyped for ~4700 study subjects. We obtain strong support for enrichment of IL-12, IL-23 and other cytokine signaling pathways. Furthermore, prioritizing variants in these enriched pathways yields support for additional disease-association variants, all of which have been independently reported in other case-control studies for Crohn's disease.

preprint2012arXiv

Polygenic Modeling with Bayesian Sparse Linear Mixed Models

Both linear mixed models (LMMs) and sparse regression models are widely used in genetics applications, including, recently, polygenic modeling in genome-wide association studies. These two approaches make very different assumptions, so are expected to perform well in different situations. However, in practice, for a given data set one typically does not know which assumptions will be more accurate. Motivated by this, we consider a hybrid of the two, which we refer to as a "Bayesian sparse linear mixed model" (BSLMM) that includes both these models as special cases. We address several key computational and statistical issues that arise when applying BSLMM, including appropriate prior specification for the hyper-parameters, and a novel Markov chain Monte Carlo algorithm for posterior inference. We apply BSLMM and compare it with other methods for two polygenic modeling applications: estimating the proportion of variance in phenotypes explained (PVE) by available genotypes, and phenotype (or breeding value) prediction. For PVE estimation, we demonstrate that BSLMM combines the advantages of both standard LMMs and sparse regression modeling. For phenotype prediction it considerably outperforms either of the other two methods, as well as several other large-scale regression methods previously suggested for this problem. Software implementing our method is freely available from http://stephenslab.uchicago.edu/software.html

preprint2012arXiv

Small World MCMC with Tempering: Ergodicity and Spectral Gap

When sampling a multi-modal distribution $π(x)$, $x\in \rr^d$, a Markov chain with local proposals is often slowly mixing; while a Small-World sampler \citep{guankrone} -- a Markov chain that uses a mixture of local and long-range proposals -- is fast mixing. However, a Small-World sampler suffers from the curse of dimensionality because its spectral gap depends on the volume of each mode. We present a new sampler that combines tempering, Small-World sampling, and producing long-range proposals from samples in companion chains (e.g. Equi-Energy sampler). In its simplest form the sampler employs two Small-World chains: an exploring chain and a sampling chain. The exploring chain samples $π_t(x) \propto π(x)^{1/t}$, $t\in [1,\infty)$, and builds up an empirical distribution. Using this empirical distribution as its long-range proposal, the sampling chain is designed to have a stationary distribution $π(x)$. We prove ergodicity of the algorithm and study its convergence rate. We show that the spectral gap of the exploring chain is enlarged by a factor of $t^{d}$ and that of the sampling chain is shrunk by a factor of $t^{-d}$. Importantly, the spectral gap of the exploring chain depends on the "size" of $π_t(x)$ while that of sampling chain does not. Overall, the sampler enlarges a severe bottleneck at the cost of shrinking a mild one, hence achieves faster mixing. The penalty on the spectral gap of the sampling chain can be significantly alleviated when extending the algorithm to multiple chains whose temperatures $\{t_k\}$ follow a geometric progression. If we allow $t_k \rightarrow 0$, the sampler becomes a global optimizer.

preprint2011arXiv

Bayesian variable selection regression for genome-wide association studies and other large-scale problems

We consider applying Bayesian Variable Selection Regression, or BVSR, to genome-wide association studies and similar large-scale regression problems. Currently, typical genome-wide association studies measure hundreds of thousands, or millions, of genetic variants (SNPs), in thousands or tens of thousands of individuals, and attempt to identify regions harboring SNPs that affect some phenotype or outcome of interest. This goal can naturally be cast as a variable selection regression problem, with the SNPs as the covariates in the regression. Characteristic features of genome-wide association studies include the following: (i) a focus primarily on identifying relevant variables, rather than on prediction; and (ii) many relevant covariates may have tiny effects, making it effectively impossible to confidently identify the complete "correct" subset of variables. Taken together, these factors put a premium on having interpretable measures of confidence for individual covariates being included in the model, which we argue is a strength of BVSR compared with alternatives such as penalized regression methods. Here we focus primarily on analysis of quantitative phenotypes, and on appropriate prior specification for BVSR in this setting, emphasizing the idea of considering what the priors imply about the total proportion of variance in outcome explained by relevant covariates. We also emphasize the potential for BVSR to estimate this proportion of variance explained, and hence shed light on the issue of "missing heritability" in genome-wide association studies.

preprint2010arXiv

A nested mixture model for protein identification using mass spectrometry

Mass spectrometry provides a high-throughput way to identify proteins in biological samples. In a typical experiment, proteins in a sample are first broken into their constituent peptides. The resulting mixture of peptides is then subjected to mass spectrometry, which generates thousands of spectra, each characteristic of its generating peptide. Here we consider the problem of inferring, from these spectra, which proteins and peptides are present in the sample. We develop a statistical approach to the problem, based on a nested mixture model. In contrast to commonly used two-stage approaches, this model provides a one-stage solution that simultaneously identifies which proteins are present, and which peptides are correctly identified. In this way our model incorporates the evidence feedback between proteins and their constituent peptides. Using simulated data and a yeast data set, we compare and contrast our method with existing widely used approaches (PeptideProphet/ProteinProphet) and with a recently published new approach, HSM. For peptide identification, our single-stage approach yields consistently more accurate results. For protein identification the methods have similar accuracy in most settings, although we exhibit some scenarios in which the existing methods perform poorly.

preprint2010arXiv

Using linear predictors to impute allele frequencies from summary or pooled genotype data

Recently-developed genotype imputation methods are a powerful tool for detecting untyped genetic variants that affect disease susceptibility in genetic association studies. However, existing imputation methods require individual-level genotype data, whereas, in practice, it is often the case that only summary data are available. For example, this may occur because, for reasons of privacy or politics, only summary data are made available to the research community at large; or because only summary data are collected, as in DNA pooling experiments. In this article we introduce a new statistical method that can accurately infer the frequencies of untyped genetic variants in these settings, and indeed substantially improve frequency estimates at typed variants in pooling experiments where observations are noisy. Our approach, which predicts each allele frequency using a linear combination of observed frequencies, is statistically straightforward, and related to a long history of the use of linear methods for estimating missing values (e.g., Kriging). The main statistical novelty is our approach to regularizing the covariance matrix estimates, and the resulting linear predictors, which is based on methods from population genetics. We find that, besides being both fast and flexible---allowing new problems to be tackled that cannot be handled by existing imputation approaches purpose-built for the genetic context---these linear methods are also very accurate. Indeed, imputation accuracy using this approach is similar to that obtained by state-of-the-art imputation methods that use individual-level data, but at a fraction of the computational cost.